"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"05/03/2021","PLAQUENILNDA   #009768","SUPPL-53","HYDROXYCHLOROQUINE SULFATE","CONCORDIA","Labeling","Approval"
"05/03/2021","OLANZAPINEANDA  #076534","SUPPL-4","OLANZAPINE","DR REDDYS LABS LTD","Labeling","Approval"
"05/03/2021","OXYCODONE AND ASPIRINANDA  #090084","SUPPL-11","ASPIRIN; OXYCODONE HYDROCHLORIDE","ACTAVIS LABS FL INC","Labeling","Approval"
"05/03/2021","NITROGLYCERINANDA  #209779","ORIG-1","NITROGLYCERIN","RUBICON","","Approval"
"05/03/2021","BUPRENORPHINEANDA  #210162","ORIG-1","BUPRENORPHINE","MYLAN TECH VIATRIS","","Approval"
"05/03/2021","SERTRALINE HYDROCHLORIDEANDA  #214790","ORIG-1","SERTRALINE HYDROCHLORIDE","ASCENT PHARMS INC","","Approval"
"05/03/2021","NIVESTYMBLA   #761080","SUPPL-7","FILGRASTIM-AAFI","HOSPIRA INC","","Approval"
"05/03/2021","ENSPRYNGBLA   #761149","SUPPL-2","SATRALIZUMAB","GENENTECH","","Approval"
"05/04/2021","OXYCODONE AND ASPIRINANDA  #040260","SUPPL-19","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/04/2021","MYCOPHENOLATE MOFETILANDA  #065520","SUPPL-25","MYCOPHENOLATE MOFETIL","MYLAN","Labeling","Approval"
"05/04/2021","MYCOPHENOLATE MOFETILANDA  #065521","SUPPL-23","MYCOPHENOLATE MOFETIL","MYLAN","Labeling","Approval"
"05/04/2021","PAROXETINE HYDROCHLORIDEANDA  #077873","SUPPL-23","PAROXETINE HYDROCHLORIDE","AUROBINDO PHARMA USA","Labeling","Approval"
"05/04/2021","PAROXETINE HYDROCHLORIDEANDA  #077873","SUPPL-25","PAROXETINE HYDROCHLORIDE","AUROBINDO PHARMA USA","Labeling","Approval"
"05/04/2021","OXYCODONE AND ASPIRINANDA  #087794","SUPPL-31","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/04/2021","DONEPEZIL HYDROCHLORIDEANDA  #090521","SUPPL-6","DONEPEZIL HYDROCHLORIDE","MYLAN PHARMS INC","Labeling","Approval"
"05/04/2021","DONEPEZIL HYDROCHLORIDEANDA  #090768","SUPPL-12","DONEPEZIL HYDROCHLORIDE","JUBILANT GENERICS","Labeling","Approval"
"05/04/2021","PAROXETINE HYDROCHLORIDEANDA  #091427","SUPPL-9","PAROXETINE HYDROCHLORIDE","AUROBINDO PHARMA USA","Labeling","Approval"
"05/04/2021","PAROXETINE HYDROCHLORIDEANDA  #091427","SUPPL-11","PAROXETINE HYDROCHLORIDE","AUROBINDO PHARMA USA","Labeling","Approval"
"05/04/2021","HYDROCODONE BITARTRATE AND IBUPROFENANDA  #091633","SUPPL-13","HYDROCODONE BITARTRATE; IBUPROFEN","SUN PHARM INDS INC","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #202357","SUPPL-14","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #202357","SUPPL-15","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #202357","SUPPL-16","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #202357","SUPPL-17","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/04/2021","ZOLEDRONIC ACIDANDA  #202472","SUPPL-5","ZOLEDRONIC ACID","ACTAVIS INC","Labeling","Approval"
"05/04/2021","ZOLEDRONIC ACIDANDA  #202472","SUPPL-6","ZOLEDRONIC ACID","ACTAVIS INC","Labeling","Approval"
"05/04/2021","DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204266","ORIG-3","DEXMETHYLPHENIDATE HYDROCHLORIDE","AUROLIFE PHARMA LLC","","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #204991","SUPPL-4","ATORVASTATIN CALCIUM","LUPIN LTD","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #204991","SUPPL-6","ATORVASTATIN CALCIUM","LUPIN LTD","Labeling","Approval"
"05/04/2021","ATORVASTATIN CALCIUMANDA  #204991","SUPPL-7","ATORVASTATIN CALCIUM","LUPIN LTD","Labeling","Approval"
"05/04/2021","DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #213099","ORIG-1","DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE","ALEMBIC","","Approval"
"05/04/2021","SODIUM ACETATEANDA  #214805","ORIG-1","SODIUM ACETATE","MILLA PHARMS","","Approval"
"05/05/2021","GANCICLOVIR SODIUMANDA  #076222","SUPPL-6","GANCICLOVIR SODIUM","HIKMA","Labeling","Approval"
"05/05/2021","KEYTRUDABLA   #125514","SUPPL-97","PEMBROLIZUMAB","MERCK SHARP DOHME","","Approval"
"05/05/2021","IRESSANDA   #206995","SUPPL-4","GEFITINIB","ASTRAZENECA","Labeling","Approval"
"05/05/2021","DAPTOMYCINNDA   #209949","SUPPL-6","DAPTOMYCIN","XELLIA PHARMS APS","Efficacy","Approval"
"05/05/2021","DAPTOMYCINNDA   #209949","SUPPL-7","DAPTOMYCIN","XELLIA PHARMS APS","Efficacy","Approval"
"05/05/2021","UPNEEQNDA   #212520","SUPPL-4","OXYMETAZOLINE HYDROCHLORIDE","RVL PHARMS","Labeling","Approval"
"05/05/2021","DROXIDOPAANDA  #214543","ORIG-1","DROXIDOPA","TRIS PHARMA INC","","Approval"
"05/06/2021","PROHANCE MULTIPACKNDA   #021489","SUPPL-16","GADOTERIDOL","BRACCO","Labeling","Approval"
"05/06/2021","VIVITROLNDA   #021897","SUPPL-55","NALTREXONE","ALKERMES","REMS","Approval"
"05/06/2021","IRBESARTANANDA  #077466","SUPPL-9","IRBESARTAN","SANDOZ","Labeling","Approval"
"05/06/2021","IRBESARTANANDA  #091236","SUPPL-15","IRBESARTAN","ALEMBIC PHARMS LTD","Labeling","Approval"
"05/06/2021","IRBESARTANANDA  #202254","SUPPL-34","IRBESARTAN","MACLEODS PHARMS LTD","Labeling","Approval"
"05/06/2021","IRBESARTANANDA  #203081","SUPPL-17","IRBESARTAN","AUROBINDO PHARMA LTD","Labeling","Approval"
"05/06/2021","PIPERACILLIN AND TAZOBACTAMANDA  #203720","SUPPL-3","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","FRESENIUS KABI","Labeling","Approval"
"05/06/2021","FYAVOLVANDA  #204213","SUPPL-6","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","LUPIN LTD","Manufacturing (CMC)","Approval"
"05/06/2021","MITIGOANDA  #204393","SUPPL-1","MORPHINE SULFATE","PIRAMAL CRITICAL","Labeling","Approval"
"05/06/2021","IRBESARTANANDA  #204774","SUPPL-10","IRBESARTAN","SCIEGEN PHARMS INC","Labeling","Approval"
"05/06/2021","ONPATTRONDA   #210922","SUPPL-9","PATISIRAN SODIUM","ALNYLAM PHARMS INC","Labeling","Approval"
"05/06/2021","CLOBAZAMANDA  #213039","ORIG-1","CLOBAZAM","ALKEM LABS LTD","","Approval"
"05/06/2021","NOREPINEPHRINE BITARTRATEANDA  #214323","ORIG-1","NOREPINEPHRINE BITARTRATE","GLAND PHARMA LTD","","Approval"
"05/07/2021","NORDETTE-21NDA   #018668","SUPPL-41","ETHINYL ESTRADIOL; LEVONORGESTREL","TEVA BRANDED PHARM","Labeling","Approval"
"05/07/2021","NORDETTE-28NDA   #018782","SUPPL-40","ETHINYL ESTRADIOL; LEVONORGESTREL","TEVA BRANDED PHARM","Labeling","Approval"
"05/07/2021","URSO 250NDA   #020675","SUPPL-27","URSODIOL","ALLERGAN","Labeling","Approval"
"05/07/2021","URSO FORTENDA   #020675","SUPPL-27","URSODIOL","ALLERGAN","Labeling","Approval"
"05/07/2021","CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860","SUPPL-7","ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE","INGENUS PHARMS NJ","Labeling","Approval"
"05/07/2021","SULINDACANDA  #073262","SUPPL-22","SULINDAC","EPIC PHARMA LLC","Labeling","Approval"
"05/07/2021","TAFINLARNDA   #202806","SUPPL-17","DABRAFENIB MESYLATE","NOVARTIS","Labeling","Approval"
"05/07/2021","MEKINISTNDA   #204114","SUPPL-18","TRAMETINIB DIMETHYL SULFOXIDE","NOVARTIS","Labeling","Approval"
"05/07/2021","LORATADINEANDA  #210409","ORIG-1","LORATADINE","HETERO LABS LTD III","","Approval"
"05/07/2021","POTASSIUM CHLORIDE 10MEQANDA  #211087","SUPPL-1","POTASSIUM CHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"05/07/2021","POTASSIUM CHLORIDE 20MEQANDA  #211087","SUPPL-1","POTASSIUM CHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"05/07/2021","POTASSIUM CHLORIDE 40MEQANDA  #211087","SUPPL-1","POTASSIUM CHLORIDE","FRESENIUS KABI USA","Manufacturing (CMC)","Approval"
"05/07/2021","TAVABOROLEANDA  #212215","ORIG-1","TAVABOROLE","TARO PHARMS","","Approval"
"05/07/2021","CARBIDOPA AND LEVODOPAANDA  #214092","ORIG-1","CARBIDOPA; LEVODOPA","SCIEGEN PHARMS INC","","Approval"
"05/10/2021","INDOMETHACINANDA  #200529","SUPPL-3","INDOMETHACIN","CHARTWELL RX","Labeling","Approval"
"05/10/2021","LEFLUNOMIDEANDA  #213497","ORIG-1","LEFLUNOMIDE","AET PHARMA","","Approval"
"05/10/2021","ERLOTINIB HYDROCHLORIDEANDA  #214366","ORIG-1","ERLOTINIB HYDROCHLORIDE","MSN","","Approval"
"05/10/2021","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDEANDA  #214698","ORIG-1","CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE","DR REDDYS","","Approval"
"05/10/2021","GABAPENTINANDA  #214956","ORIG-1","GABAPENTIN","ASCENT PHARMS INC","","Approval"
"05/11/2021","PITOCINNDA   #018261","SUPPL-41","OXYTOCIN","PAR STERILE PRODUCTS","Labeling","Approval"
"05/11/2021","DIPRIVANNDA   #019627","SUPPL-72","PROPOFOL","FRESENIUS KABI USA","Labeling","Approval"
"05/11/2021","AVAPRONDA   #020757","SUPPL-75","IRBESARTAN","SANOFI AVENTIS US","Labeling","Approval"
"05/11/2021","AVALIDENDA   #020758","SUPPL-81","HYDROCHLOROTHIAZIDE; IRBESARTAN","SANOFI AVENTIS US","Labeling","Approval"
"05/11/2021","MODAFINILANDA  #077667","SUPPL-3","MODAFINIL","APOTEX INC","Labeling","Approval"
"05/11/2021","MODAFINILANDA  #077667","SUPPL-4","MODAFINIL","APOTEX INC","Labeling","Approval"
"05/11/2021","RUFINAMIDEANDA  #204993","ORIG-1","RUFINAMIDE","HETERO LABS LTD III","","Approval"
"05/11/2021","FINGOLIMODANDA  #207940","ORIG-1","FINGOLIMOD","STANDARD CHEM AND PHARM CO LTD","","Tentative Approval"
"05/11/2021","SUBLOCADENDA   #209819","SUPPL-15","BUPRENORPHINE","INDIVIOR INC","Labeling","Approval"
"05/11/2021","SILDENAFIL CITRATEANDA  #213014","ORIG-1","SILDENAFIL CITRATE","HETERO LABS LTD V","","Approval"
"05/11/2021","CLOBAZAMANDA  #213404","ORIG-1","CLOBAZAM","MSN","","Approval"
"05/11/2021","AIMOVIGBLA   #761077","SUPPL-11","ERENUMAB-AOOE","AMGEN INC","","Approval"
"05/12/2021","ZEMPLARNDA   #020819","SUPPL-37","PARICALCITOL","ABBVIE","Manufacturing (CMC)","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-17","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-19","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-20","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-21","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-23","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076303","SUPPL-24","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-16","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-18","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-19","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-20","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-22","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #076304","SUPPL-23","FLUCONAZOLE","HOSPIRA","Labeling","Approval"
"05/12/2021","INDOMETHACINANDA  #079175","SUPPL-13","INDOMETHACIN","AVANTHI INC","Labeling","Approval"
"05/12/2021","PROLIABLA   #125320","SUPPL-207","DENOSUMAB","AMGEN","","Approval"
"05/12/2021","XGEVABLA   #125320","SUPPL-207","DENOSUMAB","AMGEN","","Approval"
"05/12/2021","INDOMETHACINANDA  #200529","SUPPL-4","INDOMETHACIN","CHARTWELL RX","Labeling","Approval"
"05/12/2021","SYNRIBONDA   #203585","SUPPL-8","OMACETAXINE MEPESUCCINATE","TEVA PHARMS INTL","Labeling","Approval"
"05/12/2021","DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREEANDA  #207442","SUPPL-4","DEXAMETHASONE SODIUM PHOSPHATE","SOMERSET THERAPS LLC","Labeling","Approval"
"05/12/2021","FULVESTRANTNDA   #210326","SUPPL-1","FULVESTRANT","FRESENIUS KABI USA","Efficacy","Approval"
"05/12/2021","FULVESTRANTNDA   #210326","SUPPL-2","FULVESTRANT","FRESENIUS KABI USA","Labeling","Approval"
"05/12/2021","TIGECYCLINENDA   #211158","SUPPL-6","TIGECYCLINE","AMNEAL","Labeling","Approval"
"05/12/2021","ZYNRELEF KITNDA   #211988","ORIG-1","BUPIVACAINE; MELOXICAM","HERON THERAPS INC","Type 4 - New Combination","Approval"
"05/12/2021","PIRFENIDONEANDA  #212615","ORIG-1","PIRFENIDONE","GRANULES INDIA","","Tentative Approval"
"05/13/2021","AGGRENOXNDA   #020884","SUPPL-40","ASPIRIN; DIPYRIDAMOLE","BOEHRINGER INGELHEIM","Labeling","Approval"
"05/13/2021","PATADAY ONCE DAILY RELIEFNDA   #021545","SUPPL-24","OLOPATADINE HYDROCHLORIDE","ALCON LABS INC","Labeling","Approval"
"05/13/2021","CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA  #090704","SUPPL-6","CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE","MYLAN PHARMS","Labeling","Approval"
"05/13/2021","CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA  #090704","SUPPL-9","CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE","MYLAN PHARMS","Labeling","Approval"
"05/13/2021","CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA  #204100","SUPPL-18","CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE","MACLEODS PHARMS LTD","Labeling","Approval"
"05/13/2021","CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA  #207455","SUPPL-4","CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE","PRINSTON INC","Labeling","Approval"
"05/13/2021","LURASIDONE HYDROCHLORIDEANDA  #213248","ORIG-1","LURASIDONE HYDROCHLORIDE","ALEMBIC","","Approval"
"05/13/2021","TIGECYCLINEANDA  #214020","ORIG-1","TIGECYCLINE","MEITHEAL","","Approval"
"05/13/2021","VIGABATRINANDA  #214992","ORIG-1","VIGABATRIN","DEXCEL","","Approval"
"05/14/2021","MAXIDEXNDA   #013422","SUPPL-46","DEXAMETHASONE","NOVARTIS","Labeling","Approval"
"05/14/2021","COLYTENDA   #018983","SUPPL-51","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MYLAN SPECIALITY LP","Labeling","Approval"
"05/14/2021","COLYTE WITH FLAVOR PACKSNDA   #018983","SUPPL-51","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MYLAN SPECIALITY LP","Labeling","Approval"
"05/14/2021","COLYTE-FLAVOREDNDA   #018983","SUPPL-51","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MYLAN SPECIALITY LP","Labeling","Approval"
"05/14/2021","GOLYTELYNDA   #019011","SUPPL-33","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","BRAINTREE","Labeling","Approval"
"05/14/2021","NULYTELYNDA   #019797","SUPPL-29","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","BRAINTREE","Labeling","Approval"
"05/14/2021","NULYTELY-FLAVOREDNDA   #019797","SUPPL-29","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","BRAINTREE","Labeling","Approval"
"05/14/2021","MIFEPREXNDA   #020687","SUPPL-24","MIFEPRISTONE","DANCO LABS LLC","REMS","Approval"
"05/14/2021","MOVIPREPNDA   #021881","SUPPL-23","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","SALIX PHARMS","Labeling","Approval"
"05/14/2021","MAXITROLNDA   #050023","SUPPL-37","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","IMPRIMIS PHARMS USA","Labeling","Approval"
"05/14/2021","MAXITROLNDA   #050065","SUPPL-65","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBREXNDA   #050541","SUPPL-31","TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBREXNDA   #050555","SUPPL-38","TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBRADEXNDA   #050592","SUPPL-44","DEXAMETHASONE; TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBRADEXNDA   #050592","SUPPL-46","DEXAMETHASONE; TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBRADEXNDA   #050616","SUPPL-40","DEXAMETHASONE; TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","TOBRADEXNDA   #050616","SUPPL-41","DEXAMETHASONE; TOBRAMYCIN","NOVARTIS","Labeling","Approval"
"05/14/2021","FENOFIBRATEANDA  #076509","SUPPL-32","FENOFIBRATE","IMPAX LABS","Labeling","Approval"
"05/14/2021","MIFEPRISTONEANDA  #091178","SUPPL-3","MIFEPRISTONE","GENBIOPRO","REMS","Approval"
"05/14/2021","PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYLANDA  #202217","SUPPL-4","BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","NOVEL LABS INC","Labeling","Approval"
"05/14/2021","BOSULIFNDA   #203341","SUPPL-20","BOSUTINIB MONOHYDRATE","PF PRISM CV","Efficacy","Approval"
"05/14/2021","BIMATOPROSTANDA  #204638","ORIG-1","BIMATOPROST","MICRO LABS LTD INDIA","","Tentative Approval"
"05/14/2021","VELTASSANDA   #205739","SUPPL-31","PATIROMER SORBITEX CALCIUM","VIFOR PHARMA","Labeling","Approval"
"05/14/2021","DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #207523","SUPPL-5","DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE","SOMERSET","Labeling","Approval"
"05/14/2021","DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #207629","ORIG-1","DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE","EUGIA PHARMA","","Approval"
"05/14/2021","PLENVUNDA   #209381","SUPPL-9","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","SALIX","Labeling","Approval"
"05/14/2021","ENZALUTAMIDEANDA  #209614","ORIG-1","ENZALUTAMIDE","ACTAVIS LABS FL INC","","Approval"
"05/14/2021","FENOFIBRATEANDA  #210606","SUPPL-3","FENOFIBRATE","GRAVITI PHARMS","Labeling","Approval"
"05/14/2021","CALCITONIN-SALMONANDA  #212416","ORIG-1","CALCITONIN SALMON","CUSTOPHARM INC","","Approval"
"05/14/2021","DEFERASIROXANDA  #214341","ORIG-1","DEFERASIROX","ANNORA PHARMA","","Approval"
"05/14/2021","EMPAVELINDA   #215014","ORIG-1","PEGCETACOPLAN","APELLIS PHARMS","Type 1 - New Molecular Entity","Approval"
"05/16/2021","ZINACEFNDA   #050558","SUPPL-76","CEFUROXIME SODIUM","PAI HOLDINGS PHARM","Labeling","Approval"
"05/16/2021","ZINACEF IN PLASTIC CONTAINERNDA   #050643","SUPPL-27","CEFUROXIME SODIUM","PAI HOLDINGS PHARM","Labeling","Approval"
"05/16/2021","GLIPIZIDEANDA  #074223","SUPPL-19","GLIPIZIDE","WATSON LABS TEVA","Labeling","Approval"
"05/17/2021","CUROSURFBLA   #020744","SUPPL-43","PORACTANT ALFA","CHIESI USA INC","","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062031","SUPPL-81","DOXYCYCLINE HYCLATE","ACTAVIS LABS FL INC","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062031","SUPPL-82","DOXYCYCLINE HYCLATE","ACTAVIS LABS FL INC","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062421","SUPPL-69","DOXYCYCLINE HYCLATE","ACTAVIS LABS FL INC","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062421","SUPPL-70","DOXYCYCLINE HYCLATE","ACTAVIS LABS FL INC","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062676","SUPPL-51","DOXYCYCLINE HYCLATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062676","SUPPL-53","DOXYCYCLINE HYCLATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062677","SUPPL-51","DOXYCYCLINE HYCLATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/17/2021","DOXYCYCLINE HYCLATEANDA  #062677","SUPPL-53","DOXYCYCLINE HYCLATE","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #065379","SUPPL-26","MYCOPHENOLATE MOFETIL","SANDOZ","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #065410","SUPPL-17","MYCOPHENOLATE MOFETIL","HIKMA","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #065413","SUPPL-17","MYCOPHENOLATE MOFETIL","HIKMA","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #065416","SUPPL-19","MYCOPHENOLATE MOFETIL","ACCORD HLTHCARE","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #065451","SUPPL-26","MYCOPHENOLATE MOFETIL","SANDOZ","Labeling","Approval"
"05/17/2021","DIAZEPAMANDA  #070311","SUPPL-21","DIAZEPAM","HIKMA","Labeling","Approval"
"05/17/2021","CATAFLAMANDA  #076561","SUPPL-9","DICLOFENAC POTASSIUM","AMICI","Labeling","Approval"
"05/17/2021","CATAFLAMANDA  #076561","SUPPL-10","DICLOFENAC POTASSIUM","AMICI","Labeling","Approval"
"05/17/2021","CATAFLAMANDA  #076561","SUPPL-13","DICLOFENAC POTASSIUM","AMICI","Labeling","Approval"
"05/17/2021","MYCOPHENOLATE MOFETILANDA  #090253","SUPPL-19","MYCOPHENOLATE MOFETIL","ACCORD HLTHCARE","Labeling","Approval"
"05/17/2021","LIOTHYRONINE SODIUMANDA  #091382","SUPPL-2","LIOTHYRONINE SODIUM","SUN PHARM","Labeling","Approval"
"05/17/2021","SKYLANDA   #203159","SUPPL-12","LEVONORGESTREL","BAYER HLTHCARE","Labeling","Approval"
"05/17/2021","DRONEDARONE HYDROCHLORIDEANDA  #205744","ORIG-1","DRONEDARONE HYDROCHLORIDE","SANDOZ INC","","Tentative Approval"
"05/17/2021","ATORVASTATIN CALCIUMANDA  #207687","SUPPL-6","ATORVASTATIN CALCIUM","ACCORD HLTHCARE","Labeling","Approval"
"05/17/2021","ATORVASTATIN CALCIUMANDA  #207687","SUPPL-9","ATORVASTATIN CALCIUM","ACCORD HLTHCARE","Labeling","Approval"
"05/17/2021","SEVELAMER CARBONATEANDA  #209374","ORIG-1","SEVELAMER CARBONATE","BIONPHARMA INC","","Approval"
"05/17/2021","METFORMIN HYDROCHLORIDEANDA  #209882","SUPPL-6","METFORMIN HYDROCHLORIDE","LAURUS","Manufacturing (CMC)","Approval"
"05/17/2021","ALIQOPANDA   #209936","SUPPL-6","COPANLISIB DIHYDROCHLORIDE","BAYER HEALTHCARE","Labeling","Approval"
"05/17/2021","ONUREGNDA   #214120","SUPPL-1","AZACITIDINE","BRISTOL","Manufacturing (CMC)","Approval"
"05/17/2021","LEVOTHYROXINE SODIUMNDA   #214253","ORIG-1","LEVOTHYROXINE SODIUM","HIKMA","Type 5 - New Formulation or New Manufacturer","Approval"
"05/18/2021","GEODONNDA   #020825","SUPPL-62","ZIPRASIDONE HYDROCHLORIDE","VIATRIS","Labeling","Approval"
"05/18/2021","GEODONNDA   #020919","SUPPL-50","ZIPRASIDONE MESYLATE","VIATRIS","Labeling","Approval"
"05/18/2021","ISENTRESSNDA   #022145","SUPPL-44","RALTEGRAVIR POTASSIUM","MSD SUB MERCK","Labeling","Approval"
"05/18/2021","ISENTRESS HDNDA   #022145","SUPPL-44","RALTEGRAVIR POTASSIUM","MSD SUB MERCK","Labeling","Approval"
"05/18/2021","ATORVASTATIN CALCIUMANDA  #091650","SUPPL-18","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/18/2021","ATORVASTATIN CALCIUMANDA  #091650","SUPPL-19","ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Labeling","Approval"
"05/18/2021","ISENTRESSNDA   #203045","SUPPL-17","RALTEGRAVIR POTASSIUM","MSD SUB MERCK","Labeling","Approval"
"05/18/2021","ISENTRESSNDA   #205786","SUPPL-9","RALTEGRAVIR POTASSIUM","MSD SUB MERCK","Labeling","Approval"
"05/18/2021","CRESEMBANDA   #207500","SUPPL-6","ISAVUCONAZONIUM SULFATE","ASTELLAS","Labeling","Approval"
"05/18/2021","CRESEMBANDA   #207501","SUPPL-5","ISAVUCONAZONIUM SULFATE","ASTELLAS","Labeling","Approval"
"05/18/2021","DOLUTEGRAVIR SODIUMANDA  #210812","ORIG-1","DOLUTEGRAVIR SODIUM","CIPLA LTD","","Tentative Approval"
"05/18/2021","TOBRAMYCIN SULFATEANDA  #211189","ORIG-1","TOBRAMYCIN SULFATE","GLAND PHARMA LTD","","Approval"
"05/18/2021","RANOLAZINEANDA  #212930","ORIG-1","RANOLAZINE","ACCORD HLTHCARE","","Approval"
"05/19/2021","XELODANDA   #020896","SUPPL-43","CAPECITABINE","CHEPLAPHARM","Labeling","Approval"
"05/19/2021","LYMPHOSEEK KITNDA   #202207","SUPPL-12","TECHNETIUM TC-99M TILMANOCEPT","CARDINAL HEALTH 414","Efficacy","Approval"
"05/19/2021","CLOFARABINEANDA  #208860","SUPPL-2","CLOFARABINE","MYLAN LABS LTD","Labeling","Approval"
"05/19/2021","ISOPROTERENOL HYDROCHLORIDEANDA  #211237","ORIG-1","ISOPROTERENOL HYDROCHLORIDE","AMRING PHARMS","","Approval"
"05/19/2021","IBSRELANDA   #211801","SUPPL-3","TENAPANOR HYDROCHLORIDE","ARDELYX INC","Labeling","Approval"
"05/19/2021","ACYCLOVIRANDA  #212444","ORIG-1","ACYCLOVIR","MACLEODS PHARMS LTD","","Approval"
"05/19/2021","AMITRIPTYLINE HYDROCHLORIDEANDA  #214548","ORIG-1","AMITRIPTYLINE HYDROCHLORIDE","UNICHEM","","Approval"
"05/20/2021","NEXAVARNDA   #021923","SUPPL-25","SORAFENIB TOSYLATE","BAYER HLTHCARE","Labeling","Approval"
"05/20/2021","OPDIVOBLA   #125554","SUPPL-92","NIVOLUMAB","BRISTOL MYERS SQUIBB","","Approval"
"05/20/2021","EVEROLIMUSANDA  #205432","ORIG-1","EVEROLIMUS","BRECKENRIDGE","","Approval"
"05/20/2021","KETOCONAZOLEANDA  #212443","ORIG-1","KETOCONAZOLE","ENCUBE","","Approval"
"05/21/2021","BACTRIMNDA   #017560","SUPPL-45","SULFAMETHOXAZOLE; TRIMETHOPRIM","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/21/2021","BACTRIM PEDIATRICNDA   #017560","SUPPL-45","SULFAMETHOXAZOLE; TRIMETHOPRIM","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/21/2021","BACTRIMNDA   #018374","SUPPL-28","SULFAMETHOXAZOLE; TRIMETHOPRIM","SUN PHARM INDS INC","Labeling","Approval"
"05/21/2021","TEMAZEPAMANDA  #070920","SUPPL-33","TEMAZEPAM","AUROBINDO PHARMA USA","Labeling","Approval"
"05/21/2021","TEMAZEPAMANDA  #071427","SUPPL-32","TEMAZEPAM","SANDOZ","Labeling","Approval"
"05/21/2021","TEMAZEPAMANDA  #071428","SUPPL-32","TEMAZEPAM","SANDOZ","Labeling","Approval"
"05/21/2021","LENALIDOMIDEANDA  #201452","ORIG-1","LENALIDOMIDE","ARROW INTL","","Approval"
"05/21/2021","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #203630","SUPPL-18","HYDROCHLOROTHIAZIDE; IRBESARTAN","AUROBINDO PHARMA LTD","Labeling","Approval"
"05/21/2021","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #203630","SUPPL-19","HYDROCHLOROTHIAZIDE; IRBESARTAN","AUROBINDO PHARMA LTD","Labeling","Approval"
"05/21/2021","PROVAYBLUENDA   #204630","SUPPL-10","METHYLENE BLUE","PROVEPHARM SAS","Labeling","Approval"
"05/21/2021","DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #204777","SUPPL-5","DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE","MICRO LABS","Labeling","Approval"
"05/21/2021","AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205187","ORIG-1","AMOXICILLIN; CLAVULANATE POTASSIUM","MICRO LABS LTD INDIA","","Approval"
"05/21/2021","BUSULFANANDA  #205672","SUPPL-3","BUSULFAN","HOSPIRA","Labeling","Approval"
"05/21/2021","BUSULFANANDA  #205672","SUPPL-4","BUSULFAN","HOSPIRA","Labeling","Approval"
"05/21/2021","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #207018","SUPPL-2","HYDROCHLOROTHIAZIDE; IRBESARTAN","UNICHEM","Labeling","Approval"
"05/21/2021","IRBESARTAN AND HYDROCHLOROTHIAZIDEANDA  #207018","SUPPL-3","HYDROCHLOROTHIAZIDE; IRBESARTAN","UNICHEM","Labeling","Approval"
"05/21/2021","BUSULFANANDA  #207050","SUPPL-3","BUSULFAN","PHARMASCIENCE INC","Labeling","Approval"
"05/21/2021","AXUMINNDA   #208054","SUPPL-34","FLUCICLOVINE F-18","BLUE EARTH","Labeling","Approval"
"05/21/2021","SIROLIMUSANDA  #211040","SUPPL-1","SIROLIMUS","NOVITIUM PHARMA","Labeling","Approval"
"05/21/2021","SIROLIMUSANDA  #211040","SUPPL-3","SIROLIMUS","NOVITIUM PHARMA","Labeling","Approval"
"05/21/2021","SIROLIMUSANDA  #211040","SUPPL-4","SIROLIMUS","NOVITIUM PHARMA","Labeling","Approval"
"05/21/2021","POTASSIUM CHLORIDEANDA  #211648","ORIG-1","POTASSIUM CHLORIDE","SAPTALIS PHARMS","","Approval"
"05/21/2021","DIAZEPAMANDA  #211998","SUPPL-3","DIAZEPAM","BELOTECA INC","Labeling","Approval"
"05/21/2021","DIAZEPAMANDA  #211998","SUPPL-4","DIAZEPAM","BELOTECA INC","Labeling","Approval"
"05/21/2021","ZINC CHLORIDEANDA  #212007","ORIG-1","ZINC CHLORIDE","EXELA PHARMA","","Approval"
"05/21/2021","ICATIBANT ACETATEANDA  #213222","ORIG-1","ICATIBANT ACETATE","GLENMARK PHARMS LTD","","Approval"
"05/21/2021","KETOCONAZOLEANDA  #213601","ORIG-1","KETOCONAZOLE","XIROMED","","Approval"
"05/21/2021","RYBREVANTBLA   #761210","ORIG-1","AMIVANTAMAB-VMJW","JANSSEN BIOTECH","","Approval"
"05/24/2021","VANCOCIN HYDROCHLORIDEANDA  #062476","SUPPL-28","VANCOMYCIN HYDROCHLORIDE","STERISCIENCE","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #062663","SUPPL-94","VANCOMYCIN HYDROCHLORIDE","FRESENIUS KABI USA","Labeling","Approval"
"05/24/2021","VANCOCIN HYDROCHLORIDEANDA  #062716","SUPPL-21","VANCOMYCIN HYDROCHLORIDE","STERISCIENCE","Labeling","Approval"
"05/24/2021","VANCOCIN HYDROCHLORIDEANDA  #062812","SUPPL-34","VANCOMYCIN HYDROCHLORIDE","STERISCIENCE","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #062911","SUPPL-61","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #062912","SUPPL-81","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #062931","SUPPL-43","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #062933","SUPPL-50","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #063076","SUPPL-43","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"05/24/2021","VANCOMYCIN HYDROCHLORIDEANDA  #065455","SUPPL-18","VANCOMYCIN HYDROCHLORIDE","HOSPIRA INC","Labeling","Approval"
"05/24/2021","NABUMETONEANDA  #076009","SUPPL-14","NABUMETONE","CHARTWELL MOLECULES","Labeling","Approval"
"05/24/2021","CYANOCOBALAMINANDA  #080737","SUPPL-40","CYANOCOBALAMIN","AM REGENT","Manufacturing (CMC)","Approval"
"05/24/2021","XTANDINDA   #213674","SUPPL-2","ENZALUTAMIDE","ASTELLAS","Labeling","Approval"
"05/25/2021","SANDOSTATINNDA   #019667","SUPPL-70","OCTREOTIDE ACETATE","NOVARTIS","Labeling","Approval"
"05/25/2021","PENTASANDA   #020049","SUPPL-35","MESALAMINE","TAKEDA PHARMS USA","Labeling","Approval"
"05/25/2021","LIALDANDA   #022000","SUPPL-22","MESALAMINE","TAKEDA PHARMS USA","Labeling","Approval"
"05/25/2021","ZIPSORNDA   #022202","SUPPL-13","DICLOFENAC POTASSIUM","ASSERTIO","Efficacy","Approval"
"05/25/2021","ZIPSORNDA   #022202","SUPPL-14","DICLOFENAC POTASSIUM","ASSERTIO","Labeling","Approval"
"05/25/2021","FLUCONAZOLEANDA  #076351","SUPPL-9","FLUCONAZOLE","MYLAN","Labeling","Approval"
"05/25/2021","FLUCONAZOLEANDA  #076351","SUPPL-11","FLUCONAZOLE","MYLAN","Labeling","Approval"
"05/25/2021","FLUCONAZOLEANDA  #076351","SUPPL-12","FLUCONAZOLE","MYLAN","Labeling","Approval"
"05/25/2021","FLUCONAZOLEANDA  #076351","SUPPL-13","FLUCONAZOLE","MYLAN","Labeling","Approval"
"05/25/2021","GLYCOPYRROLATEANDA  #091182","SUPPL-6","GLYCOPYRROLATE","KENTON","Manufacturing (CMC)","Approval"
"05/25/2021","YERVOYBLA   #125377","SUPPL-121","IPILIMUMAB","BRISTOL MYERS SQUIBB","","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #202274","SUPPL-4","VANCOMYCIN HYDROCHLORIDE","AVET LIFESCIENCES","Labeling","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #202275","SUPPL-5","VANCOMYCIN HYDROCHLORIDE","AVET LIFESCIENCES","Labeling","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #202464","SUPPL-4","VANCOMYCIN HYDROCHLORIDE","AVET LIFESCIENCES","Labeling","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #203300","SUPPL-1","VANCOMYCIN HYDROCHLORIDE","HIKMA","Labeling","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #204360","SUPPL-9","VANCOMYCIN HYDROCHLORIDE","HIKMA","Labeling","Approval"
"05/25/2021","IMPAVIDONDA   #204684","SUPPL-6","MILTEFOSINE","KNIGHT THERAPS","Labeling","Approval"
"05/25/2021","VANCOMYCIN HYDROCHLORIDEANDA  #206616","SUPPL-3","VANCOMYCIN HYDROCHLORIDE","HIKMA PHARMS","Labeling","Approval"
"05/25/2021","AMELUZNDA   #208081","SUPPL-11","AMINOLEVULINIC ACID HYDROCHLORIDE","BIOFRONTERA","Labeling","Approval"
"05/25/2021","BARHEMSYSNDA   #209510","SUPPL-3","AMISULPRIDE","ACACIA","Labeling","Approval"
"05/25/2021","CAMCEVI KITNDA   #211488","ORIG-1","LEUPROLIDE MESYLATE","ACCORD","Type 2 - New Active Ingredient","Approval"
"05/26/2021","CORZIDENDA   #018647","SUPPL-26","BENDROFLUMETHIAZIDE; NADOLOL","KING PHARMS LLC","Labeling","Approval"
"05/26/2021","MIRENANDA   #021225","SUPPL-41","LEVONORGESTREL","BAYER HLTHCARE","Labeling","Approval"
"05/26/2021","TEMAZEPAMANDA  #071174","SUPPL-26","TEMAZEPAM","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/26/2021","TEMAZEPAMANDA  #071175","SUPPL-28","TEMAZEPAM","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/26/2021","TEMAZEPAMANDA  #078581","SUPPL-10","TEMAZEPAM","SUN PHARM INDUSTRIES","Labeling","Approval"
"05/26/2021","OPSUMITNDA   #204410","SUPPL-21","MACITENTAN","ACTELION","Labeling","Approval"
"05/26/2021","PROVAYBLUENDA   #204630","SUPPL-11","METHYLENE BLUE","PROVEPHARM SAS","Labeling","Approval"
"05/26/2021","OCALIVANDA   #207999","SUPPL-7","OBETICHOLIC ACID","INTERCEPT PHARMS INC","Labeling","Approval"
"05/26/2021","DUTASTERIDEANDA  #209909","SUPPL-4","DUTASTERIDE","HUMANWELL PURACAP","Labeling","Approval"
"05/26/2021","PYLARIFYNDA   #214793","ORIG-1","PIFLUFOLASTAT F-18","PROGENICS PHARMS INC","Type 1 - New Molecular Entity","Approval"
"05/26/2021","MYFEMBREENDA   #214846","ORIG-1","ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX","MYOVANT SCIENCES","Type 4 - New Combination","Approval"
"05/27/2021","SOLU-CORTEFNDA   #009866","SUPPL-115","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Labeling","Approval"
"05/27/2021","DEPO-MEDROLNDA   #011757","SUPPL-120","METHYLPREDNISOLONE ACETATE","PFIZER","Labeling","Approval"
"05/27/2021","SOLU-MEDROLNDA   #011856","SUPPL-136","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Labeling","Approval"
"05/27/2021","JUXTAPIDNDA   #203858","SUPPL-22","LOMITAPIDE MESYLATE","AMRYT","REMS","Approval"
"05/27/2021","ATORVASTATIN CALCIUMANDA  #205519","SUPPL-24","ATORVASTATIN CALCIUM","SCIEGEN PHARMS INC","Labeling","Approval"
"05/27/2021","ATORVASTATIN CALCIUMANDA  #205519","SUPPL-25","ATORVASTATIN CALCIUM","SCIEGEN PHARMS INC","Labeling","Approval"
"05/27/2021","NUZYRANDA   #209816","SUPPL-11","OMADACYCLINE TOSYLATE","PARATEK PHARMS INC","Efficacy","Approval"
"05/27/2021","NUZYRANDA   #209817","SUPPL-10","OMADACYCLINE TOSYLATE","PARATEK PHARMS INC","Efficacy","Approval"
"05/27/2021","ZEPOSIANDA   #209899","SUPPL-1","OZANIMOD HYDROCHLORIDE","CELGENE INTL","Efficacy","Approval"
"05/27/2021","DEFERASIROXANDA  #212669","ORIG-1","DEFERASIROX","CHARTWELL RX","","Approval"
"05/27/2021","NURTEC ODTNDA   #212728","SUPPL-6","RIMEGEPANT SULFATE","PFIZER","Efficacy","Approval"
"05/27/2021","LOPERAMIDE HYDROCHLORIDE AND SIMETHICONEANDA  #214541","ORIG-1","LOPERAMIDE HYDROCHLORIDE; SIMETHICONE","GUARDIAN DRUG","","Approval"
"05/27/2021","FLUPHENAZINE HYDROCHLORIDEANDA  #214552","ORIG-1","FLUPHENAZINE HYDROCHLORIDE","ZYDUS","","Approval"
"05/28/2021","CORTISPORINNDA   #050479","SUPPL-20","HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","MONARCH PHARMS","Manufacturing (CMC)","Approval"
"05/28/2021","COSENTYXBLA   #125504","SUPPL-43","SECUKINUMAB","NOVARTIS PHARMS CORP","","Approval"
"05/28/2021","SKLICENDA   #202736","SUPPL-9","IVERMECTIN","ARBOR PHARMS LLC","Manufacturing (CMC)","Approval"
"05/28/2021","HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479","ORIG-1","ASPIRIN; HYDROCODONE BITARTRATE","LGM PHARMA","","Approval"
"05/28/2021","FULVESTRANTANDA  #209714","SUPPL-1","FULVESTRANT","HBT LABS INC","Labeling","Approval"
"05/28/2021","FULVESTRANTANDA  #209714","SUPPL-3","FULVESTRANT","HBT LABS INC","Labeling","Approval"
"05/28/2021","FULVESTRANTANDA  #209714","SUPPL-4","FULVESTRANT","HBT LABS INC","Labeling","Approval"
"05/28/2021","FULVESTRANTANDA  #209714","SUPPL-6","FULVESTRANT","HBT LABS INC","Labeling","Approval"
"05/28/2021","POMALIDOMIDEANDA  #210249","SUPPL-1","POMALIDOMIDE","EUGIA PHARMA","Labeling","Approval"
"05/28/2021","POMALIDOMIDEANDA  #210249","SUPPL-2","POMALIDOMIDE","EUGIA PHARMA","Labeling","Approval"
"05/28/2021","POMALIDOMIDEANDA  #210249","SUPPL-3","POMALIDOMIDE","EUGIA PHARMA","Labeling","Approval"
"05/28/2021","VANCOMYCIN HYDROCHLORIDENDA   #211962","SUPPL-9","VANCOMYCIN HYDROCHLORIDE","XELLIA PHARMS APS","Efficacy","Approval"
"05/28/2021","MELPHALAN HYDROCHLORIDEANDA  #212960","ORIG-1","MELPHALAN HYDROCHLORIDE","MEITHEAL","","Approval"
"05/28/2021","BIVALIRUDINANDA  #213078","ORIG-1","BIVALIRUDIN","HAINAN POLY PHARM","","Approval"
"05/28/2021","LYBALVINDA   #213378","ORIG-1","OLANZAPINE; SAMIDORPHAN L-MALATE","ALKERMES INC","Type 1 - New Molecular Entity and Type 4 - New Combination","Approval"
"05/28/2021","LYBALVINDA   #213378","ORIG-2","OLANZAPINE; SAMIDORPHAN L-MALATE","ALKERMES INC","Type 1 - New Molecular Entity and Type 4 - New Combination","Approval"
"05/28/2021","TRUSELTIQNDA   #214622","ORIG-1","INFIGRATINIB PHOSPHATE","HELSINN HLTHCARE","Type 1 - New Molecular Entity","Approval"
"05/28/2021","LUMAKRASNDA   #214665","ORIG-1","SOTORASIB","AMGEN INC","Type 1 - New Molecular Entity","Approval"
"05/31/2021","NOXAFILNDA   #205053","SUPPL-12","POSACONAZOLE","MERCK SHARP DOHME","Efficacy","Approval"
"05/31/2021","NOXAFILNDA   #205596","SUPPL-12","POSACONAZOLE","MERCK SHARP DOHME","Efficacy","Approval"
"05/31/2021","NOXAFIL POWDERMIX KITNDA   #214770","ORIG-1","POSACONAZOLE","MSD MERCK CO","Type 5 - New Formulation or New Manufacturer","Approval"